GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Buyback Yield %

Thelma Therapeutics (XKRX:015540) Buyback Yield % : 0.00 (As of Jun. 06, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Thelma Therapeutics's current buyback yield was 0.00%.


Thelma Therapeutics Buyback Yield % Historical Data

The historical data trend for Thelma Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Buyback Yield % Chart

Thelma Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.70 -12.49 -20.96 -10.34 -3.18

Thelma Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Thelma Therapeutics's Buyback Yield %

For the Specialty Business Services subindustry, Thelma Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thelma Therapeutics's Buyback Yield % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Thelma Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Thelma Therapeutics's Buyback Yield % falls into.



Thelma Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Thelma Therapeutics's Buyback Yield for the fiscal year that ended in Dec. 2021 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5000) / 157390.499
=-3.18%

Thelma Therapeutics's annualized Buyback Yield for the quarter that ended in Sep. 2022 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 157390.499
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2022) data.


Thelma Therapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thelma Therapeutics (XKRX:015540) Business Description

Traded in Other Exchanges
N/A
Address
Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines